Loading…
Aspirin inhibits NF-kappaB and protects from angiotensin II-induced organ damage
Saved in:
| Published in: | The FASEB journal 2001-08, Vol.15 (10), p.1822 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | |
|---|---|
| cites | |
| container_end_page | |
| container_issue | 10 |
| container_start_page | 1822 |
| container_title | The FASEB journal |
| container_volume | 15 |
| creator | Muller, D N Heissmeyer, V Dechend, R Hampich, F Park, J K Fiebeler, A Shagdarsuren, E Theuer, J Elger, M Pilz, B Breu, V Schroer, K Ganten, D Dietz, R Haller, H Scheidereit, C Luft, F C |
| description | |
| doi_str_mv | 10.1096/fj.00-0843fje |
| format | article |
| fullrecord | <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_11481242</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>11481242</sourcerecordid><originalsourceid>FETCH-LOGICAL-p122t-1f46e65025fcf0663535906e8bda978bac67d2b193d646aa21514c885ae7aa363</originalsourceid><addsrcrecordid>eNo1jzFPwzAUhD2AaCmMrCh_wOU9O3GcsVQUIlXAAHP1EtvBgaSWnQ78eyIB0-k-6U53jN0grBEqdef6NQAHnUvX2zO2BF0JrpTUC3aZUg8ACKgu2AIx1yhysWSvmxR89GPmxw_f-Cllzzv-SSHQfUajyUI8TradsYvHYSadn_2Y5kBdcz-aU2tNdowdjZmhgTp7xc4dfSV7_acr9r57eNs-8f3LY73d7HlAISaOLldWFSAK1zqYNxayqEBZ3RiqSt1Qq0ojGqykUbkiElhg3mpdkC2JpJIrdvvbG07NYM0hRD9Q_D78X5M_mTBOXg</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Aspirin inhibits NF-kappaB and protects from angiotensin II-induced organ damage</title><source>Wiley</source><creator>Muller, D N ; Heissmeyer, V ; Dechend, R ; Hampich, F ; Park, J K ; Fiebeler, A ; Shagdarsuren, E ; Theuer, J ; Elger, M ; Pilz, B ; Breu, V ; Schroer, K ; Ganten, D ; Dietz, R ; Haller, H ; Scheidereit, C ; Luft, F C</creator><creatorcontrib>Muller, D N ; Heissmeyer, V ; Dechend, R ; Hampich, F ; Park, J K ; Fiebeler, A ; Shagdarsuren, E ; Theuer, J ; Elger, M ; Pilz, B ; Breu, V ; Schroer, K ; Ganten, D ; Dietz, R ; Haller, H ; Scheidereit, C ; Luft, F C</creatorcontrib><identifier>ISSN: 0892-6638</identifier><identifier>DOI: 10.1096/fj.00-0843fje</identifier><identifier>PMID: 11481242</identifier><language>eng</language><publisher>United States</publisher><subject><![CDATA[Angiotensin II ; Angiotensinogen - genetics ; Animals ; Animals, Genetically Modified ; Aspirin - administration & dosage ; Aspirin - pharmacology ; Aspirin - therapeutic use ; CD4-Positive T-Lymphocytes - pathology ; CD8-Positive T-Lymphocytes - pathology ; Gene Expression ; Heart Diseases - chemically induced ; Heart Diseases - prevention & control ; Humans ; I-kappa B Kinase ; Kidney - blood supply ; Kidney - chemistry ; Kidney Diseases - chemically induced ; Kidney Diseases - prevention & control ; Macrophages - pathology ; Monocytes - pathology ; Myocarditis - pathology ; Myocarditis - prevention & control ; Myocardium - chemistry ; Nephritis - pathology ; Nephritis - prevention & control ; NF-kappa B - antagonists & inhibitors ; Protein-Serine-Threonine Kinases - antagonists & inhibitors ; Rats ; Renin - genetics ; Transcription Factor AP-1 - antagonists & inhibitors ; Vascular Cell Adhesion Molecule-1 - analysis]]></subject><ispartof>The FASEB journal, 2001-08, Vol.15 (10), p.1822</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11481242$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Muller, D N</creatorcontrib><creatorcontrib>Heissmeyer, V</creatorcontrib><creatorcontrib>Dechend, R</creatorcontrib><creatorcontrib>Hampich, F</creatorcontrib><creatorcontrib>Park, J K</creatorcontrib><creatorcontrib>Fiebeler, A</creatorcontrib><creatorcontrib>Shagdarsuren, E</creatorcontrib><creatorcontrib>Theuer, J</creatorcontrib><creatorcontrib>Elger, M</creatorcontrib><creatorcontrib>Pilz, B</creatorcontrib><creatorcontrib>Breu, V</creatorcontrib><creatorcontrib>Schroer, K</creatorcontrib><creatorcontrib>Ganten, D</creatorcontrib><creatorcontrib>Dietz, R</creatorcontrib><creatorcontrib>Haller, H</creatorcontrib><creatorcontrib>Scheidereit, C</creatorcontrib><creatorcontrib>Luft, F C</creatorcontrib><title>Aspirin inhibits NF-kappaB and protects from angiotensin II-induced organ damage</title><title>The FASEB journal</title><addtitle>FASEB J</addtitle><subject>Angiotensin II</subject><subject>Angiotensinogen - genetics</subject><subject>Animals</subject><subject>Animals, Genetically Modified</subject><subject>Aspirin - administration & dosage</subject><subject>Aspirin - pharmacology</subject><subject>Aspirin - therapeutic use</subject><subject>CD4-Positive T-Lymphocytes - pathology</subject><subject>CD8-Positive T-Lymphocytes - pathology</subject><subject>Gene Expression</subject><subject>Heart Diseases - chemically induced</subject><subject>Heart Diseases - prevention & control</subject><subject>Humans</subject><subject>I-kappa B Kinase</subject><subject>Kidney - blood supply</subject><subject>Kidney - chemistry</subject><subject>Kidney Diseases - chemically induced</subject><subject>Kidney Diseases - prevention & control</subject><subject>Macrophages - pathology</subject><subject>Monocytes - pathology</subject><subject>Myocarditis - pathology</subject><subject>Myocarditis - prevention & control</subject><subject>Myocardium - chemistry</subject><subject>Nephritis - pathology</subject><subject>Nephritis - prevention & control</subject><subject>NF-kappa B - antagonists & inhibitors</subject><subject>Protein-Serine-Threonine Kinases - antagonists & inhibitors</subject><subject>Rats</subject><subject>Renin - genetics</subject><subject>Transcription Factor AP-1 - antagonists & inhibitors</subject><subject>Vascular Cell Adhesion Molecule-1 - analysis</subject><issn>0892-6638</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNo1jzFPwzAUhD2AaCmMrCh_wOU9O3GcsVQUIlXAAHP1EtvBgaSWnQ78eyIB0-k-6U53jN0grBEqdef6NQAHnUvX2zO2BF0JrpTUC3aZUg8ACKgu2AIx1yhysWSvmxR89GPmxw_f-Cllzzv-SSHQfUajyUI8TradsYvHYSadn_2Y5kBdcz-aU2tNdowdjZmhgTp7xc4dfSV7_acr9r57eNs-8f3LY73d7HlAISaOLldWFSAK1zqYNxayqEBZ3RiqSt1Qq0ojGqykUbkiElhg3mpdkC2JpJIrdvvbG07NYM0hRD9Q_D78X5M_mTBOXg</recordid><startdate>200108</startdate><enddate>200108</enddate><creator>Muller, D N</creator><creator>Heissmeyer, V</creator><creator>Dechend, R</creator><creator>Hampich, F</creator><creator>Park, J K</creator><creator>Fiebeler, A</creator><creator>Shagdarsuren, E</creator><creator>Theuer, J</creator><creator>Elger, M</creator><creator>Pilz, B</creator><creator>Breu, V</creator><creator>Schroer, K</creator><creator>Ganten, D</creator><creator>Dietz, R</creator><creator>Haller, H</creator><creator>Scheidereit, C</creator><creator>Luft, F C</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>200108</creationdate><title>Aspirin inhibits NF-kappaB and protects from angiotensin II-induced organ damage</title><author>Muller, D N ; Heissmeyer, V ; Dechend, R ; Hampich, F ; Park, J K ; Fiebeler, A ; Shagdarsuren, E ; Theuer, J ; Elger, M ; Pilz, B ; Breu, V ; Schroer, K ; Ganten, D ; Dietz, R ; Haller, H ; Scheidereit, C ; Luft, F C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p122t-1f46e65025fcf0663535906e8bda978bac67d2b193d646aa21514c885ae7aa363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Angiotensin II</topic><topic>Angiotensinogen - genetics</topic><topic>Animals</topic><topic>Animals, Genetically Modified</topic><topic>Aspirin - administration & dosage</topic><topic>Aspirin - pharmacology</topic><topic>Aspirin - therapeutic use</topic><topic>CD4-Positive T-Lymphocytes - pathology</topic><topic>CD8-Positive T-Lymphocytes - pathology</topic><topic>Gene Expression</topic><topic>Heart Diseases - chemically induced</topic><topic>Heart Diseases - prevention & control</topic><topic>Humans</topic><topic>I-kappa B Kinase</topic><topic>Kidney - blood supply</topic><topic>Kidney - chemistry</topic><topic>Kidney Diseases - chemically induced</topic><topic>Kidney Diseases - prevention & control</topic><topic>Macrophages - pathology</topic><topic>Monocytes - pathology</topic><topic>Myocarditis - pathology</topic><topic>Myocarditis - prevention & control</topic><topic>Myocardium - chemistry</topic><topic>Nephritis - pathology</topic><topic>Nephritis - prevention & control</topic><topic>NF-kappa B - antagonists & inhibitors</topic><topic>Protein-Serine-Threonine Kinases - antagonists & inhibitors</topic><topic>Rats</topic><topic>Renin - genetics</topic><topic>Transcription Factor AP-1 - antagonists & inhibitors</topic><topic>Vascular Cell Adhesion Molecule-1 - analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Muller, D N</creatorcontrib><creatorcontrib>Heissmeyer, V</creatorcontrib><creatorcontrib>Dechend, R</creatorcontrib><creatorcontrib>Hampich, F</creatorcontrib><creatorcontrib>Park, J K</creatorcontrib><creatorcontrib>Fiebeler, A</creatorcontrib><creatorcontrib>Shagdarsuren, E</creatorcontrib><creatorcontrib>Theuer, J</creatorcontrib><creatorcontrib>Elger, M</creatorcontrib><creatorcontrib>Pilz, B</creatorcontrib><creatorcontrib>Breu, V</creatorcontrib><creatorcontrib>Schroer, K</creatorcontrib><creatorcontrib>Ganten, D</creatorcontrib><creatorcontrib>Dietz, R</creatorcontrib><creatorcontrib>Haller, H</creatorcontrib><creatorcontrib>Scheidereit, C</creatorcontrib><creatorcontrib>Luft, F C</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>The FASEB journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Muller, D N</au><au>Heissmeyer, V</au><au>Dechend, R</au><au>Hampich, F</au><au>Park, J K</au><au>Fiebeler, A</au><au>Shagdarsuren, E</au><au>Theuer, J</au><au>Elger, M</au><au>Pilz, B</au><au>Breu, V</au><au>Schroer, K</au><au>Ganten, D</au><au>Dietz, R</au><au>Haller, H</au><au>Scheidereit, C</au><au>Luft, F C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Aspirin inhibits NF-kappaB and protects from angiotensin II-induced organ damage</atitle><jtitle>The FASEB journal</jtitle><addtitle>FASEB J</addtitle><date>2001-08</date><risdate>2001</risdate><volume>15</volume><issue>10</issue><spage>1822</spage><pages>1822-</pages><issn>0892-6638</issn><cop>United States</cop><pmid>11481242</pmid><doi>10.1096/fj.00-0843fje</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0892-6638 |
| ispartof | The FASEB journal, 2001-08, Vol.15 (10), p.1822 |
| issn | 0892-6638 |
| language | eng |
| recordid | cdi_pubmed_primary_11481242 |
| source | Wiley |
| subjects | Angiotensin II Angiotensinogen - genetics Animals Animals, Genetically Modified Aspirin - administration & dosage Aspirin - pharmacology Aspirin - therapeutic use CD4-Positive T-Lymphocytes - pathology CD8-Positive T-Lymphocytes - pathology Gene Expression Heart Diseases - chemically induced Heart Diseases - prevention & control Humans I-kappa B Kinase Kidney - blood supply Kidney - chemistry Kidney Diseases - chemically induced Kidney Diseases - prevention & control Macrophages - pathology Monocytes - pathology Myocarditis - pathology Myocarditis - prevention & control Myocardium - chemistry Nephritis - pathology Nephritis - prevention & control NF-kappa B - antagonists & inhibitors Protein-Serine-Threonine Kinases - antagonists & inhibitors Rats Renin - genetics Transcription Factor AP-1 - antagonists & inhibitors Vascular Cell Adhesion Molecule-1 - analysis |
| title | Aspirin inhibits NF-kappaB and protects from angiotensin II-induced organ damage |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T03%3A56%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Aspirin%20inhibits%20NF-kappaB%20and%20protects%20from%20angiotensin%20II-induced%20organ%20damage&rft.jtitle=The%20FASEB%20journal&rft.au=Muller,%20D%20N&rft.date=2001-08&rft.volume=15&rft.issue=10&rft.spage=1822&rft.pages=1822-&rft.issn=0892-6638&rft_id=info:doi/10.1096/fj.00-0843fje&rft_dat=%3Cpubmed%3E11481242%3C/pubmed%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p122t-1f46e65025fcf0663535906e8bda978bac67d2b193d646aa21514c885ae7aa363%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/11481242&rfr_iscdi=true |